Concepción Sánchez‐Martínez

1.6k total citations · 1 hit paper
21 papers, 1.1k citations indexed

About

Concepción Sánchez‐Martínez is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Nephrology. According to data from OpenAlex, Concepción Sánchez‐Martínez has authored 21 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Pulmonary and Respiratory Medicine, 6 papers in Molecular Biology and 5 papers in Nephrology. Recurrent topics in Concepción Sánchez‐Martínez's work include Advanced Breast Cancer Therapies (7 papers), Metabolomics and Mass Spectrometry Studies (5 papers) and Cancer-related Molecular Pathways (4 papers). Concepción Sánchez‐Martínez is often cited by papers focused on Advanced Breast Cancer Therapies (7 papers), Metabolomics and Mass Spectrometry Studies (5 papers) and Cancer-related Molecular Pathways (4 papers). Concepción Sánchez‐Martínez collaborates with scholars based in Mexico, Spain and United States. Concepción Sánchez‐Martínez's co-authors include Alfonso de Dios, Marı́a José Lallena, Lawrence M. Gelbert, Rose T. Ajamie, Graham N. Wishart, Emiko L. Kreklau, Damien M. Cronier, Shufen Cai, Raquel Torres and Blake Lee Neubauer and has published in prestigious journals such as Current Medicinal Chemistry, Molecular Cancer Therapeutics and Drug Metabolism and Disposition.

In The Last Decade

Concepción Sánchez‐Martínez

21 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine

2014 446 citations Lawrence M. Gelbert, Shufen Cai et al. Investigational New Drugs profile →

Peers

Countries citing papers authored by Concepción Sánchez‐Martínez

Since Specialization

Citations

This map shows the geographic impact of Concepción Sánchez‐Martínez's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Concepción Sánchez‐Martínez with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Concepción Sánchez‐Martínez more than expected).

Fields of papers citing papers by Concepción Sánchez‐Martínez

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Concepción Sánchez‐Martínez. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Concepción Sánchez‐Martínez. The network helps show where Concepción Sánchez‐Martínez may publish in the future.

Co-authorship network of co-authors of Concepción Sánchez‐Martínez

This figure shows the co-authorship network connecting the top 25 collaborators of Concepción Sánchez‐Martínez. A scholar is included among the top collaborators of Concepción Sánchez‐Martínez based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Concepción Sánchez‐Martínez. Concepción Sánchez‐Martínez is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Charlson comorbidity index and all-cause mortality in patients with delayed hemodialysis initiation: a prospective cohort study 2025 ·BMC Nephrology ·(unknown), (unknown), Concepción Sánchez‐Martínez, (unknown), (unknown), (unknown)	1
2	Antidiabetic and Anti-Inflammatory Effect of Cinnamomum cassia Oil in Alloxan-Induced Diabetic Rats 2024 ·Pharmaceuticals ·Paula Cordero‐Pérez, (unknown), (unknown), (unknown), Concepción Sánchez‐Martínez, Liliana Torres-González, Linda E. Muñoz‐Espinosa, (unknown), (unknown), (unknown), (unknown)	1
3	Targeted and untargeted serum NMR metabolomics to reveal initial kidney disease in diabetes mellitus 2024 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), Paula Cordero‐Pérez, (unknown), Liliana Torres-González, (unknown), (unknown), Concepción Sánchez‐Martínez, Pedro Alberto García-Hernández, J. Coello, Míriam Pérez‐Trujillo, Teodor Parella, (unknown), (unknown)	1
4	Using nuclear magnetic resonance urine metabolomics to develop a prediction model of early stages of renal disease in subjects with type 2 diabetes 2022 ·Journal of Pharmaceutical and Biomedical Analysis ·(unknown), Paula Cordero‐Pérez, (unknown), (unknown), Concepción Sánchez‐Martínez, (unknown), Pedro Alberto García-Hernández, (unknown), J. Coello, Míriam Pérez‐Trujillo, Teodor Parella, Liliana Torres-González, (unknown), (unknown)	7
5	Anti-inflammatory and antioxidant activity of essential amino acid α-ketoacid analogues against renal ischemia–reperfusion damage in Wistar rats 2020 ·Biomédica ·Concepción Sánchez‐Martínez, Liliana Torres-González, (unknown), Linda E. Muñoz‐Espinosa, (unknown), (unknown), (unknown), Edelmiro Pérez‐Rodríguez, Lourdes Garza‐Ocañas, F. Garza, (unknown)	6
6	Metabolómica de la nefropatía diabética: tras la huella de indicadores de desarrollo y progresión 2020 ·Nefrología ·Paula Cordero‐Pérez, Concepción Sánchez‐Martínez, Pedro Alberto García-Hernández, (unknown)	10
7	Metabolomics of the diabetic nephropathy: behind the fingerprint of development and progression indicators 2020 ·Nefrología (English Edition) ·Paula Cordero‐Pérez, Concepción Sánchez‐Martínez, Pedro Alberto García-Hernández, (unknown)	8
8	Cyclin dependent kinase (CDK) inhibitors as anticancer drugs: Recent advances (2015–2019) 2019 ·Bioorganic & Medicinal Chemistry Letters ·Concepción Sánchez‐Martínez, Marı́a José Lallena, (unknown), Alfonso de Dios	148
9	Metabolomic and biochemical characterization of a new model of the transition of acute kidney injury to chronic kidney disease induced by folic acid 2019 ·PeerJ ·(unknown), (unknown), (unknown), Noemí Waksman de Torres, (unknown), (unknown), Concepción Sánchez‐Martínez, Edelmiro Pérez‐Rodríguez, F. Garza, Paula Cordero‐Pérez	15
10	Chronic Kidney Disease and the Search for New Biomarkers for Early Diagnosis 2018 ·Current Medicinal Chemistry ·(unknown), (unknown), (unknown), Concepción Sánchez‐Martínez, Paula Cordero‐Pérez, (unknown)	19
11	Restless legs syndrome in end-stage renal disease patients undergoing hemodialysis 2018 ·Arquivos de Neuro-Psiquiatria ·(unknown), (unknown), (unknown), Concepción Sánchez‐Martínez, (unknown), (unknown)	12
12	Levocarnitine Decreases Intradialytic Hypotension Episodes: A Randomized Controlled Trial 2017 ·Therapeutic Apheresis and Dialysis ·(unknown), (unknown), (unknown), (unknown), Raymundo Vera‐Pineda, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Concepción Sánchez‐Martínez	11
13	Brain Exposure of Two Selective Dual CDK4 and CDK6 Inhibitors and the Antitumor Activity of CDK4 and CDK6 Inhibition in Combination with Temozolomide in an Intracranial Glioblastoma Xenograft 2015 ·Drug Metabolism and Disposition ·Thomas J. Raub, Graham N. Wishart, Palaniappan Kulanthaivel, Brian A. Staton, Rose T. Ajamie, Geri A. Sawada, Lawrence M. Gelbert, Harlan E. Shannon, Concepción Sánchez‐Martínez, Alfonso de Dios	207
14	Cyclin dependent kinase (CDK) inhibitors as anticancer drugs 2015 ·Bioorganic & Medicinal Chemistry Letters ·Concepción Sánchez‐Martínez, Lawrence M. Gelbert, Marı́a José Lallena, Alfonso de Dios	199
15	Preclinical characterization of the CDK4/6 inhibitor LY2835219: in-vivo cell cycle-dependent/independent anti-tumor activities alone/in combination with gemcitabine breakdown → 2014 ·Investigational New Drugs ·Lawrence M. Gelbert, Shufen Cai, Xi Lin, Concepción Sánchez‐Martínez, Miriam Del Prado, Marı́a José Lallena, Raquel Torres, Rose T. Ajamie, Graham N. Wishart, (unknown), Blake Lee Neubauer, Jamie Young, Edward M. Chan, Philip W. Iversen, Damien M. Cronier, Emiko L. Kreklau, Alfonso de Dios	446
16	Bilateral scleritis and sclerokeratitis associated with IgA nephropathy 2012 ·Journal of Ophthalmic Inflammation and Infection ·Manuel Garza-León, (unknown), (unknown), Concepción Sánchez‐Martínez	9
17	Abstract B233: Identification and characterization of LY2835219: A potent oral inhibitor of the cyclin-dependent kinases 4 and 6 (CDK4/6) with broad in vivo antitumor activity. 2011 ·Molecular Cancer Therapeutics ·Lawrence M. Gelbert, Shufen Cai, Xi Lin, Concepción Sánchez‐Martínez, Miriam Del Prado, Marı́a José Lallena, Raquel Torres, Rose T. Ajamie, Emiko L. Kreklau, Graham N. Wishart, (unknown), Blake Lee Neubauer, Jamie Young, Edward M. Chan, (unknown), Damien M. Cronier, Alfonso de Dios	14
18	Abstract B234: LY2835219, a potent oral inhibitor of the cyclin-dependent kinases 4 and 6 (CDK4/6) that crosses the blood-brain barrier and demonstrates in vivo activity against intracranial human brain tumor xenografts. 2011 ·Molecular Cancer Therapeutics ·Concepción Sánchez‐Martínez, Lawrence M. Gelbert, Harlan E. Shannon, Alfonso de Dios, Brian A. Staton, Rose T. Ajamie, Geri A. Sawada, Graham N. Wishart, Thomas J. Raub	27
19	[Kidney transplantation. Experience at the University Hospital José González, UANL in Monterrey, Mexico]. 2011 ·PubMed ·(unknown), (unknown), (unknown), (unknown), Concepción Sánchez‐Martínez, (unknown), (unknown), Edelmiro Pérez‐Rodríguez, (unknown), (unknown), (unknown)	1
20	Dermatofibrosarcoma protuberans with areas of giant cell fibroblastoma in the vulva: a case report. 2010 ·PubMed ·(unknown), Concepción Sánchez‐Martínez, Carlos Melero Moreno, (unknown), (unknown), (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact